Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression - Yamagishi, S; Matsui, T; Nakamura, K; Inoue, H; Takeuchi, M; Ueda, S; Fukami, K; Okuda, S; Imaizumi, T (Microvasc Res, 2008)